{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:09:27Z","timestamp":1790485767738,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":406,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA167821"],"award-info":[{"award-number":["R01 CA167821"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL076438"],"award-info":[{"award-number":["R01 HL076438"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA12197"],"award-info":[{"award-number":["P30 CA12197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R33 CA121296"],"award-info":[{"award-number":["R33 CA121296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BCTR0707769"],"award-info":[{"award-number":["BCTR0707769"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43 CA174261"],"award-info":[{"award-number":["R43 CA174261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL118740"],"award-info":[{"award-number":["R01 HL118740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jcmg.2014.06.007","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T16:01:21Z","timestamp":1407772881000},"page":"824-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Noninvasive Imaging of Cardiovascular Injury Related to the Treatment of Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Suwat","family":"Kongbundansuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Gregory","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2014.06.007_bib1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific\u00a0late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"100","author":"Mertens","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmg.2014.06.007_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.med.57.121304.131240","article-title":"Cardiotoxicity induced by chemotherapy and antibody therapy","volume":"57","author":"Yeh","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/157340311799960672","article-title":"Noninvasive diagnosis of chemotherapy related cardiotoxicity","volume":"7","author":"Gillespie","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jcmg.2014.06.007_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11906-011-0229-4","article-title":"Sunitinib, hypertension, and heart failure: a model for kinase inhibitor-mediated cardiotoxicity","volume":"13","author":"Gupta","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jcmg.2014.06.007_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-12-231","article-title":"Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib","volume":"12","author":"Pantaleo","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcmg.2014.06.007_bib10","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2014.06.007_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/02841860903524396","article-title":"Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials","volume":"49","author":"Ranpura","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/djn014","article-title":"Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer","volume":"100","author":"Chapman","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmg.2014.06.007_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cncr.24219","article-title":"A\u00a0woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health","volume":"115","author":"Ewer","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jcmg.2014.06.007_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"J\u00a0Natl Cancer\u00a0Inst"},{"key":"10.1016\/j.jcmg.2014.06.007_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmg.2014.06.007_bib16","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1200\/JCO.2010.29.1567","article-title":"Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden","volume":"28","author":"Van Hemelrijck","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: seven-year experience using serial radionuclide angiocardiography","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.110.082784","article-title":"Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity","volume":"52","author":"de Geus-Oei","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/0002-8703(83)90651-8","article-title":"Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity","volume":"106","author":"McKillop","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2014.06.007_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00259-007-0694-9","article-title":"EANM\/ESC guidelines for radionuclide imaging of cardiac function","volume":"35","author":"Hesse","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/hrt.73.1.61","article-title":"Impairment of diastolic function during short-term anthracycline chemotherapy","volume":"73","author":"Cottin","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.jcmg.2014.06.007_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10549-011-1714-9","article-title":"Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer","volume":"130","author":"Cochet","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jcmg.2014.06.007_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1542\/peds.89.5.942","article-title":"Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group","volume":"89","author":"Steinherz","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcmg.2014.06.007_bib24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2003.08.011","volume":"42","author":"Klocke","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib25","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1071-3581(98)90112-X","article-title":"Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts","volume":"5","author":"Nakata","year":"1998","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0959-8049(94)00357-B","article-title":"Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy","volume":"31A","author":"Valdes Olmos","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmg.2014.06.007_bib28","first-page":"2044","article-title":"Indium-111\u2013antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity","volume":"36","author":"Carri\u00f3","year":"1995","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib29","first-page":"1283","article-title":"Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy","volume":"34","author":"Wakasugi","year":"1993","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s002590050563","article-title":"Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry","volume":"27","author":"Jeon","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2281.2001.00292.x","article-title":"Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake","volume":"21","author":"Nousiainen","year":"2001","journal-title":"Clin Physiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0735-1097(03)01065-9","volume":"42","author":"Cheitlin","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08880010500313603","article-title":"Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography","volume":"23","author":"Corapcioglu","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","article-title":"Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions","volume":"77","author":"van Royen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib35","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","article-title":"Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging","volume":"28","author":"Walker","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.echo.2012.09.001","article-title":"Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know?","volume":"25","author":"Oreto","year":"2012","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1540-8175.2012.01712.x","article-title":"Myocardial mechanics: understanding and applying three-dimensional speckle tracking echocardiography in clinical practice","volume":"29","author":"Ammar","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2014.06.007_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/echo.12079","article-title":"Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions","volume":"30","author":"Biswas","year":"2013","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2014.06.007_bib40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2012.01.037","article-title":"Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis","volume":"59","author":"Dorosz","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.echo.2010.02.015","article-title":"Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications","volume":"23","author":"Geyer","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/eurheartj\/ehn484","article-title":"Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging","volume":"30","author":"Jenkins","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2014.06.007_bib43","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.amjcard.2009.07.060","article-title":"Quantitative evaluation of regional left ventricular function using three-dimensional speckle tracking echocardiography in patients with and without heart disease","volume":"104","author":"Maffessanti","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1540-8175.2012.01773.x","article-title":"Three-dimensional speckle-tracking echocardiography: methodological aspects and clinical potential","volume":"29","author":"Urbano-Moral","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2014.06.007_bib45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1540-8175.2011.01429.x","article-title":"Left ventricular twisting and untwisting motion in childhood cancer survivors","volume":"28","author":"Cheung","year":"2011","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2014.06.007_bib46","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.09.022","article-title":"Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy","volume":"85","author":"Erven","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jcmg.2014.06.007_bib47","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/hrt.2009.173997","article-title":"Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study","volume":"96","author":"Ho","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2014.06.007_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ejechocard\/jer172","article-title":"Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy","volume":"13","author":"Motoki","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","article-title":"Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction","volume":"25","author":"Poterucha","year":"2012","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejechocard\/jer187","article-title":"Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy","volume":"12","author":"Stoodley","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-7120-5-4","article-title":"Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography","volume":"5","author":"Galderisi","year":"2007","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.jcmg.2014.06.007_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00059-011-3443-6","article-title":"Role of echocardiography in cancer care","volume":"36","author":"Raikhelkar","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.jcmg.2014.06.007_bib53","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2008-0137","article-title":"Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations","volume":"14","author":"Martin","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jcmg.2014.06.007_bib55","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcmg.2014.06.007_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0735-1097(92)90138-D","article-title":"Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans","volume":"20","author":"Stoddard","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","article-title":"Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study","volume":"7","author":"Tassan-Mangina","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-8703(89)90077-X","article-title":"Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics","volume":"118","author":"Marchandise","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2014.06.007_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00392-011-0406-0","article-title":"Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy","volume":"101","author":"Lange","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib63","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J\u00a0Am So Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib64","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy\u2013a systematic review","volume":"63","author":"Thavendirananthan","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1540-8175.2011.01618.x","article-title":"Tissue Doppler, triplane echocardiography, and speckle tracking echocardiography: different ways of measuring longitudinal myocardial velocity and deformation parameters. A comparative clinical study","volume":"29","author":"Fontana","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2014.06.007_bib66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.echo.2008.09.009","article-title":"American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography","volume":"11","author":"Mulvaqh","year":"2008","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2014.06.007_bib67","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.105.561514","article-title":"Pericardial disease","volume":"113","author":"Little","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.06.007_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2214\/AJR.07.3112","article-title":"Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients","volume":"191","author":"Rademaker","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib69","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1200\/JCO.2009.25.2627","article-title":"Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma","volume":"28","author":"Kupeli","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00019501-200603000-00008","article-title":"Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation","volume":"17","author":"Apter","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jcmg.2014.06.007_bib71","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcmg.2014.06.007_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ctrv.2010.12.004","article-title":"Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease","volume":"37","author":"van Leeuwen-Segarceanu","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jcmg.2014.06.007_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2009.09.005","article-title":"Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma","volume":"105","author":"Andersen","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib74","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1016\/j.ejrad.2012.02.002","article-title":"Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis","volume":"81","author":"Asferg","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib75","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"55","author":"Hundley","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib76","first-page":"66","article-title":"Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance","volume":"15","author":"Vasu","year":"2013","journal-title":"JCMR"},{"key":"10.1016\/j.jcmg.2014.06.007_bib77","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib78","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","article-title":"Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines","volume":"110","author":"Neilan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib79","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib80","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease CME","volume":"6","author":"Drafts","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2014.06.007_bib81","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12350-012-9512-2","article-title":"Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs","volume":"19","author":"Jiji","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib82","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1055\/s-2004-813416","article-title":"Anthrazyklin-induzierte Kardiotoxizit\u00e4t: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer]","volume":"176","author":"Oberholzer","year":"2004","journal-title":"Rofo"},{"issue":"Suppl 1","key":"10.1016\/j.jcmg.2014.06.007_bib83","doi-asserted-by":"crossref","first-page":"P53","DOI":"10.1186\/1532-429X-15-S1-P53","article-title":"T2 mapping in different cardiomyopathies: first clinical experience","volume":"15","author":"Bonner","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2014.06.007_bib84","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCIMAGING.109.918540","article-title":"Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model","volume":"3","author":"Lightfoot","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib85","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","article-title":"Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging\u2014a pilot study","volume":"141","author":"Wassmuth","year":"2001","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.jcmg.2014.06.007_bib86","doi-asserted-by":"crossref","first-page":"P276","DOI":"10.1186\/1532-429X-13-S1-P276","article-title":"Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy","volume":"13","author":"Tham","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2014.06.007_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2459\/JCM.0b013e3280104155","article-title":"Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy","volume":"8","author":"Catalano","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jcmg.2014.06.007_bib88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.semnuclmed.2004.09.006","article-title":"Cardiovascular molecular imaging","volume":"35","author":"Dobrucki","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mrm.1910170112","article-title":"31P NMR spectroscopy in chronic adriamycin cardiotoxicity","volume":"17","author":"Bittner","year":"1991","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib90","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2009.23.8527","article-title":"Aortic stiffness increases upon receipt of anthracyclin chemotherapy","volume":"28","author":"Chaosuwannakit","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12253-012-9589-6","article-title":"Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer","volume":"19","author":"Jenei","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jcmg.2014.06.007_bib92","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2214\/AJR.07.2822","article-title":"Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue","volume":"190","author":"Wiginton","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib93","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-007-9068-4","article-title":"Noninvasive imaging of apoptosis in cardiovascular disease","volume":"13","author":"Korngold","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jcmg.2014.06.007_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccl.2008.12.008","article-title":"New molecular imaging targets to characterize myocardial biology","volume":"27","author":"Morrison","year":"2009","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jcmg.2014.06.007_bib95","first-page":"842","article-title":"Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats","volume":"45","author":"Bennink","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib96","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2310\/7290.2008.00015","article-title":"Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography","volume":"7","author":"Gabrielson","year":"2008","journal-title":"Mol Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib97","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.jacc.2007.02.060","article-title":"Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model","volume":"49","author":"Panjrath","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib98","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/mrm.20617","article-title":"Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle","volume":"54","author":"Sosnovik","year":"2005","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1254\/jphs.FP0050980","article-title":"Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in\u00a0vitro and rat cardiac ventricles in\u00a0vivo","volume":"101","author":"Ueno","year":"2006","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jcmg.2014.06.007_bib100","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.bmcl.2006.07.045","article-title":"Synthesis, radiolabeling, and in\u00a0vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis","volume":"16","author":"Zhou","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jcmg.2014.06.007_bib101","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00006231-200209000-00011","article-title":"High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction","volume":"23","author":"Valdes Olmos","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jcmg.2014.06.007_bib102","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1071-3581(97)90008-8","article-title":"Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity","volume":"4","author":"Maini","year":"1997","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/nbm.1940040104","article-title":"Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR","volume":"4","author":"Dobrucki Dekker","year":"1991","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jcmg.2014.06.007_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF03006439","article-title":"Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings","volume":"17","author":"Saito","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mnc.2000.108351","article-title":"Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method","volume":"7","author":"Saito","year":"2000","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib106","first-page":"293","article-title":"A\u00a0novel clinical indicator using cardiac technetium-99m sestamibi kinetics for evaluating cardiotoxicity in cancer patients treated with multiagent chemotherapy","volume":"2","author":"Carboni","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.jcmg.2014.06.007_bib107","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4329\/wjr.v4.i5.220","article-title":"Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: evidence of early chemotherapeutic cardiotoxicity?","volume":"4","author":"Borde","year":"2012","journal-title":"World J Radiol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib108","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.2010.0270","article-title":"Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer","volume":"21","author":"Toubert","year":"2011","journal-title":"Thyroid"},{"issue":"Suppl 2","key":"10.1016\/j.jcmg.2014.06.007_bib109","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.2967\/jnumed.107.045922","article-title":"Multimodality molecular imaging of tumor angiogenesis","volume":"49","author":"Cai","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib110","first-page":"75","article-title":"Targeted molecular imaging of angiogenesis in PET and SPECT: a review","volume":"85","author":"Stacy","year":"2012","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib111","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJM200109273451312","article-title":"Trastuzumab and breast cancer","volume":"345","author":"Behr","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.06.007_bib112","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO.2005.03.8448","article-title":"Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer","volume":"24","author":"Perik","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib113","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ejca.2007.06.024","article-title":"111-Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2\u00a0expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity","volume":"43","author":"de Korte","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmg.2014.06.007_bib114","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2014.06.007_bib115","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring,\u00a0management, prevention, and research directions: a scientific statement for the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.06.007_bib116","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/annonc\/mdn728","article-title":"Expert opinion of the use of anthracyclines in patients with advanced breast cancer at cardiac risk","volume":"20","author":"Barrett-Lee","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmg.2014.06.007_bib117","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11739-011-0744-y","article-title":"Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology","volume":"7","author":"Raschi","year":"2012","journal-title":"Intern Emerg Med"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X14004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X14004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:40:52Z","timestamp":1761846052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X14004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1936878X14004495"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2014.06.007","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Imaging of Cardiovascular Injury Related to the Treatment of Cancer","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2014.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}